HSPD1 and atrial fibrillation: When HSP65 is attacked by circulating anti-HSP65 antibodies, it can cause a damaging autoimmune response mediated by complement-dependent cytotoxicity, leading to myocyte injury, electro-anatomical substrate formation, and in turn AF.